General Medicine and Primary Care - Prova Education

Episodes 1-16 of 116

Warm Autoimmune Hemolytic Anemia: How Antibody-Based Therapies Are Revolutionizing Its Management
Warm Autoimmune Hemolytic Anemia: How Antibody-Based Therapies Are Revolutionizing Its Management
CME/CE
Warm Autoimmune Hemolytic Anemia: How Antibody-Based Therapies Are Revolutionizing Its Management
0.25 credits
- Caroline Piatek, MD
- Irina Murakhovskaya, MD
0.25 credits
Pediatric Narcolepsy: Timely Diagnosis, Treatment, and Outcome Optimization
Pediatric Narcolepsy: Timely Diagnosis, Treatment, and Outcome Optimization
CME/CE
Pediatric Narcolepsy: Timely Diagnosis, Treatment, and Outcome Optimization
1.00 credit
- Anne Marie Morse, DO, FAASM
1.00 credit
Is Gout Hiding in the Nephrology Clinic?
Is Gout Hiding in the Nephrology Clinic?
MinuteCE®
Is Gout Hiding in the Nephrology Clinic?
- Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
What’s New About Gout? Rheumatology Perspective
What’s New About Gout? Rheumatology Perspective
MinuteCE®
What’s New About Gout? Rheumatology Perspective
- Richard Johnson, MD
- John K. Botson, MD, RPh
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®
Center of the Target: Which Patients Are Most Likely to Develop Gout?
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
MinuteCE®
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
- Brittany Weber, MD, PhD
Should We Look for Gout in the Cardiology Clinic?
Should We Look for Gout in the Cardiology Clinic?
MinuteCE®
Should We Look for Gout in the Cardiology Clinic?
- Richard Johnson, MD
- Brittany Weber, MD, PhD
Gout Beyond the Joints: What’s the Hidden Danger?
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®
Gout Beyond the Joints: What’s the Hidden Danger?
- Richard Johnson, MD
Can You Manage Patients With Uncontrolled Gout More Effectively?
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®
Can You Manage Patients With Uncontrolled Gout More Effectively?
- Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
What Are the Emerging Therapies for Managing Gout?
What Are the Emerging Therapies for Managing Gout?
MinuteCE®
What Are the Emerging Therapies for Managing Gout?
- Richard Johnson, MD
- John K. Botson, MD, RPh
What’s New About Gout? Nephrology Perspective
What’s New About Gout? Nephrology Perspective
MinuteCE®
What’s New About Gout? Nephrology Perspective
- Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
Treat or Refer: Who Is Responsible for Managing Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®
Treat or Refer: Who Is Responsible for Managing Gout?
- John K. Botson, MD, RPh
- Abdul Abdellatif, MD, FASN
Is Managing Gout in the Nephrology Clinic a Challenge?
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®
Is Managing Gout in the Nephrology Clinic a Challenge?
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
CME/CE
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
- Mazen Noureddin, MD, MHSc
Assessing a Patient’s Willingness to Accept Treatment for AUD
Assessing a Patient’s Willingness to Accept Treatment for AUD
MinuteCE®
Assessing a Patient’s Willingness to Accept Treatment for AUD
- Edwin A. Salsitz, MD, DFASAM
How, When, and Why to Conduct Brief AUD Interventions
How, When, and Why to Conduct Brief AUD Interventions
MinuteCE®
How, When, and Why to Conduct Brief AUD Interventions
- Edwin A. Salsitz, MD, DFASAM

Prev
1
2
3
…
7
8
Next

1/6